Infliximab - Graft versus Host Disease (GVHD)
You are here : Home > Formulary Search > Infliximab - Graft versus Host Disease (GVHD)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Infliximab
Indication :
Graft versus Host Disease (GVHD)
Group Name :
Keywords :
Brand Names Include :
Inflectra, Remicade, Remsima
Important Information :
Specialist centres only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Infliximab is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Graft versus Host Disease (GVHD).
Committee Recommendations (1)
16 Apr 18 -
Not Set
This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Treatment should remain with the specialist (RED) hospital only drug.
GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.
Treatment should remain with the specialist (RED) hospital only drug.
GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.